BTIG Reiterates Buy on GeneDx Holdings, Maintains $90 Price Target

Benzinga · 1d ago
BTIG analyst Mark Massaro reiterates GeneDx Holdings (NASDAQ:WGS) with a Buy and maintains $90 price target.